- Report
- March 2024
- 200 Pages
Global
From €3982EUR$4,150USD£3,430GBP
- Report
- February 2024
- 200 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- October 2023
- 233 Pages
Global
From €3056EUR$3,185USD£2,632GBP
€4366EUR$4,550USD£3,760GBP
- Report
- June 2023
- 285 Pages
Global
From €3838EUR$4,000USD£3,306GBP
- Report
- March 2024
- 150 Pages
From €4980EUR$5,190USD£4,289GBP
- Report
- September 2019
- 70 Pages
China
From €2015EUR$2,100USD£1,735GBP
€2878EUR$3,000USD£2,479GBP
- Report
- April 2023
- 113 Pages
Global
From €4558EUR$4,750USD£3,925GBP
- Report
- July 2022
- 100 Pages
Global
From €2639EUR$2,750USD£2,273GBP
- Report
- August 2021
- 210 Pages
Global
From €3838EUR$4,000USD£3,306GBP
- Report
- October 2023
- 102 Pages
Global
From €3500EUR$3,908USD£3,120GBP
The Transmucosal Drug Delivery market is a subset of the Transdermal and Transmucosal Drug Delivery market. It is a method of delivering drugs through the mucous membranes of the body, such as the mouth, nose, and rectum. This method of drug delivery is advantageous because it allows for rapid absorption of the drug into the bloodstream, bypassing the digestive system. It is also beneficial for drugs that are not easily absorbed through the digestive system, such as peptides and proteins.
Transmucosal drug delivery is used for a variety of therapeutic applications, including pain management, hormone replacement therapy, and the treatment of allergies and asthma. It is also used to deliver vaccines and other medications to the body.
Some companies in the Transmucosal Drug Delivery market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Sanofi. These companies are involved in the research, development, and manufacture of transmucosal drug delivery systems. Show Less Read more
